Authors: Shih, C Gossett, LS Gruber, JM Grossman, CS Andis, SL Schultz, RM Worzalla, JF Corbett, TH Metz, JT

Citation: C. Shih et al., Synthesis and biological evaluation of novel cryptophycin analogs with modification in the beta-alanine region, BIOORG MED, 9(1), 1999, pp. 69-74

Authors: Gossett, LS Habeck, LL Shackelford, KA Mendelsohn, LG Gates, SB Worzalla, JF Self, TD Theobald, KS Andis, SL Schultz, RM Shih, C

Citation: Ls. Gossett et al., The synthesis and biological activity of a series of 2,4-diaminopyrido[2,3-D] pyrimidine based antifolates as antineoplastic and antiarthritic agents, BIOORG MED, 9(1), 1999, pp. 75-78

Authors: Schultz, RM Patel, VF Worzalla, JF Shih, CA

Citation: Rm. Schultz et al., Role of thymidylate synthase in the antitumor activity of the multitargeted antifolate, LY231514, ANTICANC R, 19(1A), 1999, pp. 437-443

Authors: Tonkinson, JL Worzalla, JF Teng, CH Mendelsohn, LG

Citation: Jl. Tonkinson et al., Cell cycle modulation by a multitargeted antifolate, LY231514, increases the cytotoxicity and antitumor activity of gemcitabine in HT29 colon carcinoma, CANCER RES, 59(15), 1999, pp. 3671-3676

Authors: Mendelsohn, LG Worzalla, JF Walling, JM

Citation: Lg. Mendelsohn et al., Preclinical and clinical evaluation of the glycinamide ribonucleotide formyltransferase inhibitors lometrexol and LY309887, CANC DRUG, 1999, pp. 261-280

Authors: Worzalla, JF Shih, C Schultz, RM

Citation: Jf. Worzalla et al., Role of folic acid in modulating the toxicity and efficacy of the multitargeted antifolate, LY231514, ANTICANC R, 18(5A), 1998, pp. 3235-3239